Loading…

3D-Image guided robotic-assisted partial nephrectomy: a multi-institutional propensity score-matched analysis (UroCCR study 51)

Purpose Robot-assisted partial nephrectomy (RAPN) is a difficult procedure with risk of significant perioperative complications. The objective was to evaluate the impact of preoperative planning and intraoperative guidance with 3D model reconstructions on perioperative outcomes of RAPN. Methods We c...

Full description

Saved in:
Bibliographic Details
Published in:World journal of urology 2023-02, Vol.41 (2), p.303-313
Main Authors: Michiels, Clément, Khene, Zine-Eddine, Prudhomme, Thomas, Boulenger de Hauteclocque, Astrid, Cornelis, François H., Percot, Mélanie, Simeon, Hélène, Dupitout, Laure, Bensadoun, Henri, Capon, Grégoire, Alezra, Eric, Estrade, Vincent, Bladou, Franck, Robert, Grégoire, Ferriere, Jean-Marie, Grenier, Nicolas, Doumerc, Nicolas, Bensalah, Karim, Bernhard, Jean-Christophe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Robot-assisted partial nephrectomy (RAPN) is a difficult procedure with risk of significant perioperative complications. The objective was to evaluate the impact of preoperative planning and intraoperative guidance with 3D model reconstructions on perioperative outcomes of RAPN. Methods We conducted a retrospective analysis of all patients who underwent RAPN for kidney tumor by three high-volume expert surgeons from academic centers. Clinical data were collected prospectively after written consent into the French kidney cancer network database UroCCR (CNIL-DR 2013-206; NCT03293563). Our cohort was divided into two groups: 3D-Image guided RAPN group (3D-IGRAPN) and control group. A propensity score according to age, pre-operative renal function and RENAL tumor complexity score was used. Both surgical techniques were compared in terms of perioperative outcomes. Results The initial study cohort included 230 3D-IGRAPN and 415 control RAPN. Before propensity-score matching, patients in the 3D-IGRAPN group had a larger tumor (4.3 cm vs. 3.5 cm, P  
ISSN:1433-8726
0724-4983
1433-8726
DOI:10.1007/s00345-021-03645-1